Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-123676
Filing Date
2004-07-23
Accepted
2004-07-23 15:26:23
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2003 d10ka.htm 10-K/A 643666
2 CONSENT OF KPMG LLP dex23.htm EX-23 2452
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6624
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6628
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3539
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3543
  Complete submission text file 0001193125-04-123676.txt   668732
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-10736 | Film No.: 04928987
SIC: 2834 Pharmaceutical Preparations